Vertex Pharmaceuticals (VRTX) Current Assets (2009 - 2026)

Vertex Pharmaceuticals' Current Assets history runs 18 years deep, the most recent figure standing at $11.7 billion for Q1 2026.

• In Q1 2026, Current Assets rose 17.2% year-over-year to $11.7 billion; the TTM figure through Mar 2026 stood at $11.7 billion (up 17.2% YoY), while the FY2025 annual figure was $11.2 billion, up 16.72% from the prior year.
• Current Assets was $11.7 billion for Q1 2026 at Vertex Pharmaceuticals, up from $11.2 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $14.7 billion in Q3 2023 to a low of $8.9 billion in Q2 2024.
• Historically, Current Assets has averaged $11.7 billion across 5 years, with a median of $11.5 billion in 2022.
• The sharpest annual moves came in 2022 and 2024: Current Assets soared 38.62% in 2022, then plunged 35.55% in 2024.
• A 5-year view of Current Assets shows it stood at $13.2 billion in 2022, then grew by 6.87% to $14.1 billion in 2023, then tumbled by 32.15% to $9.6 billion in 2024, then gained by 16.72% to $11.2 billion in 2025, then gained by 4.73% to $11.7 billion in 2026.
• The last three Current Assets figures came in at $11.7 billion (Q1 2026), $11.2 billion (Q4 2025), and $10.6 billion (Q3 2025), per Business Quant data.